Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030

Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030

The Biologics Contract Development & Manufacturing Organization Market size was estimated at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030.

Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract development and manufacturing organizations (CDMOs) comprise companies specialized in developing, producing, and manufacturing biopharmaceutical products derived from living organisms. These organizations offer end-to-end services to pharmaceutical and biotech companies that require assistance bringing their innovative biological-based products to market. The development of the biologics CDMO market is influenced by several factors, such as an increase in demand for biopharmaceuticals due to the increasing prevalence of chronic conditions and aging people. Additionally, the advancement in bioprocessing technologies has enabled efficient large-scale production with reduced costs. However, stringent regulatory requirements imposed by authorities for product quality control throughout the manufacturing process may hamper the market demand. New opportunities are emerging within the industry due to advancements in personalized medicine and targeted therapy approaches requiring novel biological treatments. A surge in interest in next-generation biotherapeutics such as multi-specifics or bispecific antibodies, antibody-drug conjugates (ADCs), and gene editing technologies is expected to create a lucrative market opportunity in the forecasted period.Regional InsightsThe Americas has a significant landscape in the biologics contract development and manufacturing market due to several well-established CDMOs and its robust regulatory environment governed by the FDA. In the context of biologics contract development and manufacturing organizations (CDMOs), Europe holds immense potential due to significant investment in research and development (R&D). With well-funded institutions and universities scattered across the continent, Europe has established itself as a global center for scientific innovation. The growth of the APAC region is driven by rising healthcare expenditure, increasing investments in the pharmaceutical and biotechnology sectors, favorable government policies to promote research and development (R&D), and a burgeoning demand for advanced therapeutics driven by an increasing prevalence of chronic conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biologics Contract Development & Manufacturing Organization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biologics Contract Development & Manufacturing Organization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biologics Contract Development & Manufacturing Organization Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Abzena Ltd., Aenova Holding GmbH, AGC Biologics GmbH, Avid Bioservices, Inc., Binex Co. Limited, Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Emergent BioSolutions, Inc., Fujifilm Holdings Corporation, Icon PLC, JSR Life Sciences, LLC, Lonza Group AG, Parexel International Corporation, ProBioGen AG, Recipharm AB, Rentschler Biopharma SE, Samsung Biologics, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., Toyobo Co., Ltd., and WuXi Biologics Inc..

Market Segmentation & Coverage



This research report categorizes the Biologics Contract Development & Manufacturing Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Mammalian
Non-mammalian
Product Type
Biologics
Antisense & Molecular Therapy
Monoclonal
Recombinant Proteins
Vaccines
Biosimilars
Disease Indication
Cardiovascular Disorders
Hematological Disorders
Immunological Disorders
Oncology
Service Type
Cell Line Development
Mammalian
Microbial
Process Development
Downstream
Impurity, Isolation, & Identification
Pharmaceutical Analysis
Physicochemical Characterization
Upstream
Mammalian
Microbial
End-User
Biopharmaceutical Companies
Research Laboratories
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biologics Contract Development & Manufacturing Organization Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biologics Contract Development & Manufacturing Organization Market?
3. What are the technology trends and regulatory frameworks in the Biologics Contract Development & Manufacturing Organization Market?
4. What is the market share of the leading vendors in the Biologics Contract Development & Manufacturing Organization Market?
5. Which modes and strategic moves are suitable for entering the Biologics Contract Development & Manufacturing Organization Market?

Note: PDF & Excel + Online Access - 1 Year